Product Recommendations NGAL- Early Marker of Acute Kidney Injury

What is NGAL? The full name of NGAL is human lipocalin 2 (Ln2) or siderocalin. It belongs to the lipocalin family and is the earliest proposed marker of acute kidney injury (AKI).   What is the clinical significance of NGAL? 1. NGAL is a marker of acute kidney injury (AKI) When AKI occurs

Acute Kidney Injury and Chronic Kidney Disease as Interconnected Syndromes

Serum and urinary biomarkers to predict acute kidney injury in premature infants: a systematic review and meta-analysis of diagnostic accuracy

Biomarkers for acute kidney injury: is NGAL ready for clinical use?

Clinical Application of Renal Biomarkers

Definitions of acute kidney injury. Definitions of acute kidney injury

Biomarkers in acute kidney injury: Evidence or paradigm? - ScienceDirect

Neutrophil Gelatinase-assoc Lipocalin (NGAL): promising biomarker of acute kidney injury.

Diagnostics, Free Full-Text

Frontiers Predictive value of neutrophil gelatinase-associated lipocalin in children with acute kidney injury: A systematic review and meta-analysis

Product Recommendations NGAL- Early Marker of Acute Kidney Injury

The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome Type 3

Pediatric acute kidney injury: prevalence, impact and management chall

Acute kidney injury in the critically ill: an updated review on pathophysiology and management